Accueil
Envoyer à un ami
Imprimer
Grand
Petit
Partager
ACTUALITES

Takeda to Present Broad Range of Clinical Data During 58th American Society of Hematology ...


- 3 Novembre 2016 modifié le 1 Janvier 1970


– Demonstrating Expertise and Leadership in Hematologic Oncology, Presentations Include Phase 3 Data on ADCETRIS® (brentuximab vedotin) in CD30-Positive Cutaneous T-Cell Lymphoma, NINLAROTM (ixazomib) in Relapsed/Refractory Multiple Myeloma and Emerging Pipeline –

– Presentations Underscore Takeda's Ongoing Commitment to Transform Care for Patients Affected by Blood Cancers –

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited http://me-newswire.net//news/18984/en...



ACTUALITES | INTERNATIONAL | TCHAD | POLITIQUE | CULTURE | EXCLUSIF | Revue de Presse | English News | 中國